Logotype for AXT Inc

AXT (AXTI) Q2 2024 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for AXT Inc

Q2 2024 earnings summary

2 Feb, 2026

Executive summary

  • Q2 2024 revenue reached $27.9 million, up 23% sequentially and 50% year-over-year, driven by strong demand for indium phosphide, gallium arsenide, and germanium substrates, especially in AI, data center, and optical network applications.

  • Gross profit rose to $7.7 million, with gross margin improving to 27.4% from 9.2% in Q2 2023, reflecting higher unit volumes and favorable product mix.

  • Non-GAAP net loss narrowed to $0.8 million ($0.02/share), and GAAP net loss was $1.5 million ($0.04/share), both improving significantly year-over-year.

  • The company continues to pursue the IPO of its subsidiary Tongmei on the STAR Market in China, with the process under regulatory review and positive feedback from the exchange.

  • Management highlighted tangible signs of market recovery and successful execution in a dynamic technology landscape.

Financial highlights

  • Q2 2024 revenue: $27.9 million, up from $22.7 million in Q1 2024 and $18.6 million in Q2 2023.

  • Gross margin: 27.4% (GAAP), up from 9.2% in Q2 2023; non-GAAP gross margin: 27.6%.

  • Non-GAAP operating loss: $1.2 million; GAAP operating loss: $1.9 million, both improved year-over-year.

  • Cash, equivalents, and investments: $43.3 million as of June 30, 2024; cash and cash equivalents: $27.8 million; short-term investments: $1.7 million.

  • Inventory at June 30, 2024: $85.8 million, with reserves for excess and obsolete inventory at $23.1 million.

Outlook and guidance

  • Q3 2024 revenue expected between $25.0 million and $27.0 million.

  • Non-GAAP net loss projected at $0.06–$0.08/share; GAAP net loss at $0.07–$0.09/share.

  • Management expects continued growth opportunities in AI and optical transceivers, with some quarter-to-quarter variability as end markets normalize.

  • The company believes it has adequate cash and investments to meet operating needs and capital expenditures over the next 12 months.

  • Indium phosphide and raw material revenues expected to hold steady; gallium arsenide and germanium to moderate due to order timing and inventory digestion.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more